FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998264625> ?p ?o ?g. }

• W1998264625 endingPage "1222" @default.
• W1998264625 startingPage "1215" @default.
• W1998264625 abstract "There is a current requirement for novel therapeutic strategies for the treatment of hematopoietic tumors. Residual tumor cells are the main origin of tumor relapse. The aim of this study was to eliminate the residual tumor cells of hematopoietic tumors. Cytokine‑induced killer (CIK) cells are used in immunotherapy to deplete the residual cells. However, it is necessary to increase the antitumor activity and clinical applicability of CIK cells. The present study investigated the antitumor activity of CIK cells to the SU‑DHL2 human B‑cell lymphoma and K562 human chronic myelogenous leukemia cell lines. CD3+CD56+ cells from healthy donors were expanded in culture with cytokines and anti‑CD20 monoclonal antibody (mAb; rituximab) to generate CIK cells. A preliminary investigation of their mechanism was then performed. The increase in the cytotoxicity of the CIK cells induced by the anti‑CD20 mAb was associated with an increase in the expression of cytotoxic factors. The expression of components of the signal transducer and activator of transcription (STAT) and mitogen‑activated protein kinase/extracellular signal‑regulated kinase (MAPK/ERK) signaling pathways was found to increase. Upregulation of the expression of STAT1, STAT3 and STAT5 is important as these co‑stimulatory molecules enhance T‑cell proliferation. Activation of the MAPK signaling pathway is a possible mechanism for the anti‑apoptosis effect on the proliferation of CIK cells. In conclusion, anti‑CD20 mAb may play an important role in the improvement of CIK‑mediated cytotoxicity to tumor cells. These observations may aid in the improvement of the effects of immunotherapy in depleting the residual cells of hematopoietic tumors. Thus, the use of CIK cells cultured with anti‑CD20 mAb could be a novel therapeutic strategy for the depletion of chemotherapy‑resistant or residual cells in anaplastic large and B‑cell lymphoma." @default.
• W1998264625 created "2016-06-24" @default.
• W1998264625 creator A5034649465 @default.
• W1998264625 creator A5035981893 @default.
• W1998264625 creator A5077931358 @default.
• W1998264625 creator A5079596084 @default.
• W1998264625 creator A5088208044 @default.
• W1998264625 creator A5089086011 @default.
• W1998264625 date "2015-02-05" @default.
• W1998264625 modified "2023-10-14" @default.
• W1998264625 title "Anti-CD20 antibody induces the improvement of cytokine-induced killer cell activity via the STAT and MAPK/ERK signaling pathways" @default.
• W1998264625 cites W1481357784 @default.
• W1998264625 cites W1520055338 @default.
• W1998264625 cites W1981629491 @default.
• W1998264625 cites W1981813507 @default.
• W1998264625 cites W1983134200 @default.
• W1998264625 cites W1983431609 @default.
• W1998264625 cites W1986420083 @default.
• W1998264625 cites W1990773283 @default.
• W1998264625 cites W2068055816 @default.
• W1998264625 cites W2072170105 @default.
• W1998264625 cites W2086485522 @default.
• W1998264625 cites W2096514882 @default.
• W1998264625 cites W2099561543 @default.
• W1998264625 cites W2120142068 @default.
• W1998264625 cites W2144751606 @default.
• W1998264625 cites W2146438882 @default.
• W1998264625 cites W2147548158 @default.
• W1998264625 cites W2153665789 @default.
• W1998264625 cites W2160305510 @default.
• W1998264625 cites W2163280406 @default.
• W1998264625 cites W2167571754 @default.
• W1998264625 cites W2172202574 @default.
• W1998264625 cites W2396628363 @default.
• W1998264625 cites W2397875978 @default.
• W1998264625 cites W4234125692 @default.
• W1998264625 doi "https://doi.org/10.3892/etm.2015.2264" @default.
• W1998264625 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4353788" @default.
• W1998264625 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25780412" @default.
• W1998264625 hasPublicationYear "2015" @default.
• W1998264625 type Work @default.
• W1998264625 sameAs 1998264625 @default.
• W1998264625 citedByCount "7" @default.
• W1998264625 countsByYear W19982646252017 @default.
• W1998264625 countsByYear W19982646252018 @default.
• W1998264625 countsByYear W19982646252019 @default.
• W1998264625 countsByYear W19982646252020 @default.
• W1998264625 crossrefType "journal-article" @default.
• W1998264625 hasAuthorship W1998264625A5034649465 @default.
• W1998264625 hasAuthorship W1998264625A5035981893 @default.
• W1998264625 hasAuthorship W1998264625A5077931358 @default.
• W1998264625 hasAuthorship W1998264625A5079596084 @default.
• W1998264625 hasAuthorship W1998264625A5088208044 @default.
• W1998264625 hasAuthorship W1998264625A5089086011 @default.
• W1998264625 hasBestOaLocation W19982646251 @default.
• W1998264625 hasConcept C154317977 @default.
• W1998264625 hasConcept C159654299 @default.
• W1998264625 hasConcept C171122931 @default.
• W1998264625 hasConcept C171958077 @default.
• W1998264625 hasConcept C18031839 @default.
• W1998264625 hasConcept C202751555 @default.
• W1998264625 hasConcept C203014093 @default.
• W1998264625 hasConcept C2777701055 @default.
• W1998264625 hasConcept C2778461978 @default.
• W1998264625 hasConcept C2778923194 @default.
• W1998264625 hasConcept C502942594 @default.
• W1998264625 hasConcept C55493867 @default.
• W1998264625 hasConcept C57074206 @default.
• W1998264625 hasConcept C62478195 @default.
• W1998264625 hasConcept C86803240 @default.
• W1998264625 hasConcept C8891405 @default.
• W1998264625 hasConcept C95444343 @default.
• W1998264625 hasConceptScore W1998264625C154317977 @default.
• W1998264625 hasConceptScore W1998264625C159654299 @default.
• W1998264625 hasConceptScore W1998264625C171122931 @default.
• W1998264625 hasConceptScore W1998264625C171958077 @default.
• W1998264625 hasConceptScore W1998264625C18031839 @default.
• W1998264625 hasConceptScore W1998264625C202751555 @default.
• W1998264625 hasConceptScore W1998264625C203014093 @default.
• W1998264625 hasConceptScore W1998264625C2777701055 @default.
• W1998264625 hasConceptScore W1998264625C2778461978 @default.
• W1998264625 hasConceptScore W1998264625C2778923194 @default.
• W1998264625 hasConceptScore W1998264625C502942594 @default.
• W1998264625 hasConceptScore W1998264625C55493867 @default.
• W1998264625 hasConceptScore W1998264625C57074206 @default.
• W1998264625 hasConceptScore W1998264625C62478195 @default.
• W1998264625 hasConceptScore W1998264625C86803240 @default.
• W1998264625 hasConceptScore W1998264625C8891405 @default.
• W1998264625 hasConceptScore W1998264625C95444343 @default.
• W1998264625 hasIssue "4" @default.
• W1998264625 hasLocation W19982646251 @default.
• W1998264625 hasLocation W19982646252 @default.
• W1998264625 hasLocation W19982646253 @default.
• W1998264625 hasLocation W19982646254 @default.
• W1998264625 hasOpenAccess W1998264625 @default.
• W1998264625 hasPrimaryLocation W19982646251 @default.
• W1998264625 hasRelatedWork W1974032072 @default.
• W1998264625 hasRelatedWork W2044592821 @default.

• next